Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
about
Idiopathic (primary) achalasia: a reviewPeroral endoscopic myotomy for achalasiaThe Pathogenesis and Management of Achalasia: Current Status and Future DirectionsThe spectrum of achalasia: lessons from studies of pathophysiology and high-resolution manometryNew insights into the pathophysiology of achalasia and implications for future treatmentAre anti-ganglioside antibodies associated with proventricular dilatation disease in birds?Achalasia - an update.Demographic, clinical features and treatment outcomes in 700 achalasia patients in iran.2011 update on esophageal achalasia.Idiopathic (primary) achalasia.Achalasia--An Autoimmune Inflammatory Disease: A Cross-Sectional Study.New insights into human enteric neuropathies.Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus.Oesophageal motor functions and its disorders.Human enteric neuropathies: morphology and molecular pathology.The lower oesophageal sphincter.Severe recurrent achalasia cardia responding to treatment of severe autoimmune acquired haemophilia.Endoscopic treatment of esophageal achalasia.Achalasia: physiology and etiopathogenesis.Enteric autoantibodies and gut motility disorders.Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease.Surgical treatment for achalasia: when should it be performed, and for which patients?The involvement of nitric oxide synthase neurons in enteric neuropathies.Pathogenesis of achalasia cardia.Achalasia: new perspectives on an old disease.The pathogenesis of proventricular dilatation disease.Anti-enteric neuronal antibodies and the irritable bowel syndromeNovel mechanism for impaired nitrergic relaxation in achalasia.Immunohistochemical study of the muscularis externa of the esophagus in achalasia patients.Achalasia and viral infection: new insights from veterinary medicine.Genetic variation in the lymphotoxin-α (LTA)/tumour necrosis factor-α (TNFα) locus as a risk factor for idiopathic achalasia.Achalasia following reflux disease: coincidence, consequence, or accommodation? An experience-based literature review.The prevalence of autoimmune disease in patients with esophageal achalasia.Autoantibodies in patients with gut motility disorders and enteric neuropathy.HLA and enteric antineuronal antibodies in patients with achalasia.
P2860
Q26801313-2B2A53CC-FFAD-4E80-878B-F5056DD38B8CQ26822257-8928E929-F5EC-45AB-9E05-7D00912E6D53Q27011546-B65BB93E-855E-4787-9065-DD5A8A8C36E6Q27027666-C118AFD3-22ED-42FA-933F-F494C587CA1FQ28068914-E34008A0-0722-464D-B9ED-CEE0C601350BQ33561954-62E26792-4A89-4BAF-8CA7-7EB17577B510Q34028403-54AF47A9-D87E-4FB4-890A-EACDC35FE35CQ34134520-404A0714-4903-40DE-9501-2EC3DFA53699Q34270601-137C387D-0FFF-47EC-A226-8D480E0E2C36Q34583301-0B54F752-CE12-4546-95BE-F7FE74681670Q35675896-D92625A1-A4BB-458A-AC47-0C0F859595DFQ35738984-108F5722-355E-4441-9A01-173C2EC9FFE4Q35760265-A50659E1-F13A-40AC-BF94-F93C0EBC4C98Q35884378-0FB2DFE4-12BB-411C-996E-D79D7B28B361Q35925745-6194FB18-D9C0-4F65-A235-2882F7B4B589Q36100734-49772F72-14FB-46D7-80E4-C28B2ED13C38Q36382898-72131163-0E9F-4EF6-A5ED-B7CFA59CF888Q36493448-52CF7AA5-CF2F-4DB3-8ED1-091C5589528CQ36546454-7758B2EE-520E-4BD5-A237-886EC95FD0EBQ36750462-9F71EAC8-EF3F-4141-829A-73A80BEFDB76Q36949822-0E5D2C52-5BBC-410B-9CB2-EB08AD226B7DQ37889738-004DDDC1-482F-4967-A282-385671C41242Q37927166-96D6389F-7AEE-4CC3-9E9F-69F87CFBA7C3Q38026029-BCD4E149-3B67-42AE-AA95-AF3E5D4EEE95Q38675487-0895D6FC-BE01-400C-A233-235341BF49ECQ39117335-9584F2AC-0BA4-4261-8E8E-837E2703BFC7Q40818420-9D5F4EFC-601A-4C50-9299-42F9DEB0788AQ42212480-E132A076-1F55-49EF-BAE7-B3E46BA59577Q46371941-4B3BAE75-5B82-49DB-8D8E-CBD280FAB3A4Q46925723-6009ACAC-BEB9-42F3-A87F-C1FF6C213A70Q48858412-2C77FDAE-4531-4201-BAB4-9F574BC94BCCQ49639026-5B715841-5FB4-4B97-9B86-2D33E04DBF27Q51010123-99A9A007-03C4-4B0A-882F-489F67DFB894Q53227770-B73009B3-8E68-4C84-93ED-AD7194796F04Q54597141-2E10B798-B301-488C-99F1-37F5BCCF9995
P2860
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
@ast
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
@en
type
label
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
@ast
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
@en
prefLabel
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
@ast
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease.
@en
P2093
P2860
P356
P1433
P1476
Antineuronal antibodies in idiopathic achalasia and gastro-oesophageal reflux disease
@en
P2093
J B Meddings
R I Rothstein
P2860
P304
P356
10.1136/GUT.52.5.629
P407
P577
2003-05-01T00:00:00Z